You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 55 No. 4, April 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Cerebrovascular Disease
 •Alert me on articles by topic

Stroke 1998

Arch Neurol. 1998;55:448.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

IN THIS issue of the ARCHIVES and the April 22/29 issue of JAMA, attention is being directed toward important, emerging areas involving the treatment, prevention, and outcome predictors of stroke. A vital area of clinical research interest is posterior circulation ischemia and stroke. Our knowledge of posterior circulation disease has not developed as completely as that of anterior circulation. Therapy for vertebrobasilar disease has remained an area of intense controversy. Caplan1 establishes perspective and cautions us in his lead editorial in this issue when he advises us how to proceed with the latest therapeutic modality, recombinant tissue-typplasminogen activator, in patients of the kind described by Grond et al2 with vertebrobasilar stroke. Of considerable interest is that Grond et al2 found a favorable outcome in the majority of their patients with vertebrobasilar stroke when they were treated with intravenous recombinant tissue-type plasminogen activator and heparin within 3 hours of symptom . . . [Full Text of this Article]


RELATED ARTICLES

Vertebrobasilar Disease and Thrombolytic Treatment
Louis R. Caplan
Arch Neurol. 1998;55(4):450-451.
EXTRACT | FULL TEXT  

Potential Effects of Common Drugs on Stroke Recovery
Larry B. Goldstein
Arch Neurol. 1998;55(4):454-456.
ABSTRACT | FULL TEXT  

Treating Ischemic Stroke as an Emergency
Harold P. Adams, Jr
Arch Neurol. 1998;55(4):457-461.
ABSTRACT | FULL TEXT  

Early Intravenous Thrombolysis With Recombinant Tissue-type Plasminogen Activator in Vertebrobasilar Ischemic Stroke
Martin Grond, Jobst Rudolf, Susanne Schmülling, Christoph Stenzel, Michael Neveling, and Wolf-Dieter Heiss
Arch Neurol. 1998;55(4):466-469.
ABSTRACT | FULL TEXT  

Proximal Extracranial Vertebral Artery Disease in the New England Medical Center Posterior Circulation Registry
Robert J. Wityk, Hui M. Chang, Axel Rosengart, Wen-Chaing Han, L. Dana DeWitt, Michael S. Pessin, and Louis R. Caplan
Arch Neurol. 1998;55(4):470-478.
ABSTRACT | FULL TEXT  

Different Predictors of Neurological Worsening in Different Causes of Stroke
Haruko Yamamoto, Julien Bogousslavsky, and Guy van Melle
Arch Neurol. 1998;55(4):481-486.
ABSTRACT | FULL TEXT  

Prognostic Value of Proton Magnetic Resonance Spectroscopy in Ischemic Stroke
Francesco Federico, Isabella Laura Simone, Vincenzo Lucivero, Paolo Giannini, Giuseppe Laddomada, Domenico Maria Mezzapesa, and Carla Tortorella
Arch Neurol. 1998;55(4):489-494.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.